Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products
Prospective, Single Site, Controlled Comparative Study to Identify and Assess Tissue Responses After Injection With Various Biostimulatory Products
Sponsor: Merz North America, Inc.
Listed as NCT06093815, this NA trial focuses on Injection Site Reaction and remains completed. Sponsored by Merz North America, Inc., it has been updated 5 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Jan 2025 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Jan 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Nov 2023 — Jun 2024 [monthly]
Recruiting NA
First recorded
Sep 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Merz North America, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .